Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01207778 · ClinicalTrials.gov registry record

Brain Imaging and Developmental Follow up of Infants Treated With Erythropoietin

A clinical trial, sponsored by University of New Mexico.

Completed
Registry status
77
Enrollment target

NCT01207778: Completed study, sponsored by University of New Mexico.

NCT01207778 is a clinical trial that has completed, run by University of New Mexico. The registered enrollment target is 77 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01207778 has completed, sponsored by University of New Mexico.

COMPLETED
Registry status
77 participants
Enrollment target

Study Summary

Approximately 60,000 premature infants are born each year who weigh less than 1,500 grams,many of whom sustain brain damage because of their prematurity. This study is designed to evaluate the long-term developmental effects of one promising neuroprotective treatment,erythropoietin (Epo), when given in the neonatal period. Using detailed neurodevelopmental testing and state-of-the-art brain imaging, we hope to determine whether this is an effective treatment to prevent brain injury associated with prematurity, and to lay the groundwork for further studies to improve the developmental outcome of infants delivered prematurely.

Primary Outcome

Infants who received ESAs during their initial hospitalization will perform significantly better on measures of the Wechsler Preschool and Primary Scale of Intelligence (WPPSI) full scale IQ, performance IQ, verbal IQ, and executive function. Scores are standardized, 100 is an average score with a standard deviation of 15. Higher scores are better. Test scores range from 41 to 160.

Trial Details

FieldValue
Enrollment Target 77 participants
Start Date 2010-03
Est. Completion 2020-12-31
University of New Mexico

168 total trials

What the finished NCT01207778 record still lists

NCT01207778 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 77 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT01207778 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01207778 about?

NCT01207778 is a clinical study titled "Brain Imaging and Developmental Follow up of Infants Treated With Erythropoietin". Approximately 60,000 premature infants are born each year who weigh less than 1,500 grams,many of whom sustain brain damage because of their prematurity. This study is designed to evaluate the long-term developmental effects of one promising neuroprotective treatment,erythropoietin (Epo), when given...

What is the current status of trial NCT01207778?

This trial is currently completed. The enrollment target is 77 participants. The study started on 2010-03. Estimated completion is 2020-12-31.

Who is sponsoring clinical trial NCT01207778?

This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02127398 · 77 participants · Phase 2

    Stool Transplants to Treat Refractory Clostridium Difficile Colitis

  • NCT04159103 · 77 participants · Phase 1

    Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia

  • NCT04683003 · 77 participants · Phase 3

    A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura

  • NCT05004116 · 77 participants · Phase 1

    A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01207778, the US trial registry maintained by the National Library of Medicine. NCT01207778 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.